| Rank | Company | Revenue | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 101 | $2.68B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 102 | $2.67B | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 103 | $2.60B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 104 | $2.60B | Healthcare | Healthcare Providers | United States | NYSE | |
| 105 | $2.59B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 106 | $2.58B | Healthcare | Healthcare Providers | United States | NYSE | |
| 107 | $2.54B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 108 | $2.49B | Healthcare | Healthcare Providers | United States | NYSE | |
| 109 | $2.44B | Healthcare | Biotechnology | United States | Nasdaq | |
| 110 | $2.36B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 111 | $2.30B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 112 | $2.30B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 113 | $2.29B | Healthcare | Healthcare Providers | United States | NYSE | |
| 114 | $2.27B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 115 | $2.25B | Healthcare | Medical Devices | United States | NYSE | |
| 116 | $2.23B | Healthcare | Biotechnology | United States | Nasdaq | |
| 117 | $2.19B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 118 | $2.16B | Healthcare | Medical Devices | United States | Nasdaq | |
| 119 | $2.03B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 120 | $1.97B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 121 | $1.95B | Healthcare | Healthcare Providers | United States | NYSE | |
| 122 | $1.95B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 123 | $1.86B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 124 | $1.84B | Healthcare | Medical Devices | United States | NYSE | |
| 125 | $1.67B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 126 | $1.66B | Healthcare | Biotechnology | United States | Nasdaq | |
| 127 | $1.65B | Healthcare | Medical Devices | United States | Nasdaq | |
| 128 | $1.58B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 129 | $1.58B | Healthcare | Medical Devices | United States | Nasdaq | |
| 130 | $1.56B | Healthcare | Healthcare Providers | United States | NYSE | |
| 131 | $1.56B | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 132 | $1.52B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 133 | $1.50B | Healthcare | Medical Devices | United States | NYSE | |
| 134 | $1.50B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 135 | $1.48B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 136 | $1.47B | Healthcare | Medical Devices | United States | Nasdaq | |
| 137 | $1.46B | Healthcare | Pharmaceutical Retailers | United States | NYSE | |
| 138 | $1.37B | Healthcare | Medical Devices | United States | NYSE | |
| 139 | $1.35B | Healthcare | Medical Devices | United States | NYSE | |
| 140 | $1.33B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 141 | $1.31B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 142 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 143 | $1.22B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 144 | $1.22B | Healthcare | Biotechnology | United States | Nasdaq | |
| 145 | $1.18B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 146 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 147 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 148 | $1.14B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 149 | $1.12B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 150 | $1.10B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 151 | $1.10B | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 152 | $1.09B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 153 | $1.04B | Healthcare | Medical Devices | United States | Nasdaq | |
| 154 | $1.02B | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 155 | $1.02B | Healthcare | Medical Devices | United States | Nasdaq | |
| 156 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 157 | $990M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 158 | $990M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 159 | $985M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 160 | $978M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 161 | $960M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 162 | $941M | Healthcare | Biotechnology | United States | Nasdaq | |
| 163 | $912M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 164 | $899M | Healthcare | Medical Devices | United States | NYSE | |
| 165 | $884M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 166 | $881M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 167 | $874M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 168 | $841M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 169 | $833M | Healthcare | Medical Devices | United States | Nasdaq | |
| 170 | $831M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 171 | $830M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 172 | $825M | Healthcare | Medical Devices | United States | Nasdaq | |
| 173 | $815M | Healthcare | Medical Devices | United States | Nasdaq | |
| 174 | $812M | Healthcare | Healthcare Providers | United States | NYSE | |
| 175 | $808M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 176 | $807M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 177 | $800M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 178 | $785M | Healthcare | Biotechnology | United States | Nasdaq | |
| 179 | $777M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 180 | $770M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 181 | $746M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 182 | $730M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 183 | $717M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 184 | $713M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 185 | $699M | Healthcare | Medical Devices | United States | Nasdaq | |
| 186 | $690M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 187 | $686M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 188 | $669M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 189 | $668M | Healthcare | Medical Devices | United States | Nasdaq | |
| 190 | $632M | Healthcare | Medical Devices | United States | Nasdaq | |
| 191 | $618M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 192 | $617M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 193 | $613M | Healthcare | Medical Devices | United States | NYSE | |
| 194 | $606M | Healthcare | Biotechnology | United States | Nasdaq | |
| 195 | $591M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 196 | $588M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 197 | $582M | Healthcare | Medical Devices | United States | Nasdaq | |
| 198 | $575M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 199 | $570M | Healthcare | Medical Devices | United States | Nasdaq | |
| 200 | $569M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |